Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

immunization

- PMLiVE

BioNTech to acquire UK AI start-up InstaDeep in deal worth over £560m

The deal will enable drug discovery and development of immunotherapies and vaccines

- PMLiVE

Genentech and Kronos Bio announce oncology partnership worth over $570m

The companies aim to advance novel therapies for transcriptional targets in oncology

- PMLiVE

AbbVie and Anima Biotech collaborate on mRNA biology modulators

The biotech could receive up to $540m in milestone payments for three targets

- PMLiVE

Research Partnership announces new CEO Gareth Phillips

Phillips was previously UK managing director and head of EMEA at Ipsos

- PMLiVE

Moderna and CytomX to partner in deal worth up to 1.2bn

The companies plan to develop mRNA-based therapies for a wide range of diseases

- PMLiVE

AstraZeneca to acquire CinCor Pharma in deal worth up to $1.8bn

The deal will strengthen AZ’s cardiorenal pipeline through the addition of baxdrostat

- PMLiVE

AbbVie and Immunome agree on multi-year oncology collaboration

The companies will identify up to ten antibody-target pairs using Immunome's discovery engine

- PMLiVE

Pfizer and Gero collaborate on fibrotic disease research

The companies will use data to identify genes and pathways linked to fibrotic diseases

- PMLiVE

Boehringer Ingelheim and 3T Biosciences in cancer research agreement

The immunotherapy company could receive $268m in milestone payments

- PMLiVE

SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO

Porterhouse extends a very warm welcome to Isaac Batley

Porterhouse Medical Group

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

It is no secret that Pharma (still) has a major diversity problem.

Impetus Digital

- PMLiVE

IGNIFI ANNOUNCES NEW LEADERSHIP TEAM FOR NEXT PHASE OF GROWTH

Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next...

IGNIFI

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links